In vivo detection of optically-evoked opioid peptide release

  1. Ream Al-Hasani  Is a corresponding author
  2. Jenny-Marie T Wong
  3. Omar S Mabrouk
  4. Jordan G McCall
  5. Gavin P Schmitz
  6. Kirsten A Porter-Stransky
  7. Brandon J Aragona
  8. Robert T Kennedy  Is a corresponding author
  9. Michael R Bruchas  Is a corresponding author
  1. Washington University School of Medicine, United States
  2. University of Michigan, United States

Abstract

Though the last decade has seen accelerated advances in techniques and technologies to perturb neuronal circuitry in the brain, we are still poorly equipped to adequately dissect endogenous peptide release in vivo. To this end we developed a system that combines in vivo optogenetics with microdialysis and a highly sensitive mass spectrometry-based assay to measure opioid peptide release in freely moving rodents.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files

Article and author information

Author details

  1. Ream Al-Hasani

    Department of Anesthesiology, Division of Basic Research, Washington University School of Medicine, St Louis, United States
    For correspondence
    al-hasanir@wustl.edu
    Competing interests
    No competing interests declared.
  2. Jenny-Marie T Wong

    Department of Chemistry, University of Michigan, Ann Arbor, United States
    Competing interests
    No competing interests declared.
  3. Omar S Mabrouk

    Department of Chemistry, University of Michigan, Ann Arbor, United States
    Competing interests
    No competing interests declared.
  4. Jordan G McCall

    Department of Anesthesiology, Division of Basic Research, Washington University School of Medicine, St Louis, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8295-0664
  5. Gavin P Schmitz

    Department of Anesthesiology, Division of Basic Research, Washington University School of Medicine, St Louis, United States
    Competing interests
    No competing interests declared.
  6. Kirsten A Porter-Stransky

    Department of Psychology, University of Michigan, Ann Arbor, United States
    Competing interests
    No competing interests declared.
  7. Brandon J Aragona

    Department of Psychology, University of Michigan, Ann Arbor, United States
    Competing interests
    No competing interests declared.
  8. Robert T Kennedy

    Department of Chemistry, University of Michigan, Ann Arbor, United States
    For correspondence
    rtkenn@umich.edu
    Competing interests
    No competing interests declared.
  9. Michael R Bruchas

    Department of Anesthesiology, Division of Basic Research, Washington University School of Medicine, St Louis, United States
    For correspondence
    bruchasm@wustl.edu
    Competing interests
    Michael R Bruchas, Co-founder of Neurolux, Inc, a company that is making wireless optogenetic probes. None of the work in this manuscript used these devices or is related to any of the company's activities, but we list this information here in full disclosure.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4713-7816

Funding

National Institute on Drug Abuse (K99/R00 Pathway to Independence DA038725)

  • Ream Al-Hasani

National Institute of Mental Health (F31 MH101956)

  • Jordan G McCall

National Institute of Biomedical Imaging and Bioengineering (R01 EB003320)

  • Robert T Kennedy

National Institute on Drug Abuse (R01 DA033396)

  • Michael R Bruchas

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Julie A Kauer, Brown University, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of Washington University in St. Louis and the University of Michigan.

Version history

  1. Received: March 9, 2018
  2. Accepted: September 2, 2018
  3. Accepted Manuscript published: September 3, 2018 (version 1)
  4. Version of Record published: September 12, 2018 (version 2)

Copyright

© 2018, Al-Hasani et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,448
    views
  • 615
    downloads
  • 60
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ream Al-Hasani
  2. Jenny-Marie T Wong
  3. Omar S Mabrouk
  4. Jordan G McCall
  5. Gavin P Schmitz
  6. Kirsten A Porter-Stransky
  7. Brandon J Aragona
  8. Robert T Kennedy
  9. Michael R Bruchas
(2018)
In vivo detection of optically-evoked opioid peptide release
eLife 7:e36520.
https://doi.org/10.7554/eLife.36520

Share this article

https://doi.org/10.7554/eLife.36520

Further reading

    1. Neuroscience
    Daniel Hoops, Robert Kyne ... Cecilia Flores
    Short Report

    Dopamine axons are the only axons known to grow during adolescence. Here, using rodent models, we examined how two proteins, Netrin-1 and its receptor, UNC5C, guide dopamine axons toward the prefrontal cortex and shape behaviour. We demonstrate in mice (Mus musculus) that dopamine axons reach the cortex through a transient gradient of Netrin-1-expressing cells – disrupting this gradient reroutes axons away from their target. Using a seasonal model (Siberian hamsters; Phodopus sungorus) we find that mesocortical dopamine development can be regulated by a natural environmental cue (daylength) in a sexually dimorphic manner – delayed in males, but advanced in females. The timings of dopamine axon growth and UNC5C expression are always phase-locked. Adolescence is an ill-defined, transitional period; we pinpoint neurodevelopmental markers underlying this period.

    1. Neuroscience
    Baba Yogesh, Georg B Keller
    Research Article

    Acetylcholine is released in visual cortex by axonal projections from the basal forebrain. The signals conveyed by these projections and their computational significance are still unclear. Using two-photon calcium imaging in behaving mice, we show that basal forebrain cholinergic axons in the mouse visual cortex provide a binary locomotion state signal. In these axons, we found no evidence of responses to visual stimuli or visuomotor prediction errors. While optogenetic activation of cholinergic axons in visual cortex in isolation did not drive local neuronal activity, when paired with visuomotor stimuli, it resulted in layer-specific increases of neuronal activity. Responses in layer 5 neurons to both top-down and bottom-up inputs were increased in amplitude and decreased in latency, whereas those in layer 2/3 neurons remained unchanged. Using opto- and chemogenetic manipulations of cholinergic activity, we found acetylcholine to underlie the locomotion-associated decorrelation of activity between neurons in both layer 2/3 and layer 5. Our results suggest that acetylcholine augments the responsiveness of layer 5 neurons to inputs from outside of the local network, possibly enabling faster switching between internal representations during locomotion.